| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 30,000 | $0.19 | $5,718.00 | -0.6% | - | - | |
| Nov 12, 2025 | COLL Collegium Pharmaceutical, Inc | Fallon John A. | Director | Sell | 34,853 | $47.21 | $1,645,535.60 | -35.0% | -1.3% | - | |
| Nov 12, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita53 | Executive Vice President | Sell | 131,856 | $11.92 | $1,571,723.52 | -47.4% | +24.0% | - | |
| Nov 12, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 305,000 | $1,011.18 | $308,411,204.36 | - | +0.7% | - | |
| Nov 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 19,900 | $40.94 | $814,706.00 | -39.0% | +10.2% | - | |
| Nov 12, 2025 | JNJ Johnson & Johnson | Johnson & Johnson59 | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | +22.6% | - | |
| Nov 12, 2025 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 7,500 | $14.18 | $106,350.00 | +75.9% | +1.6% | - | |
| Nov 11, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 283,131 | $986.64 | $279,347,679.79 | - | +5.7% | - | |
| Nov 11, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $450.10 | $3,600,829.70 | -60.1% | +3.0% | - | |
| Nov 10, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 16,869 | $972.52 | $16,405,395.92 | - | +8.1% | - | |
| Nov 10, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $42.53 | $112,151.61 | -1.7% | -52.9% | - | |
| Nov 10, 2025 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 21,000 | $452.07 | $9,493,483.38 | -9.7% | +4.2% | - | |
| Nov 10, 2025 | ASRT Assertio Holdings, Inc. | Stark David Matthew53 | Director | Sell | 8,959 | $0.76 | $6,806.15 | -8.3% | +0.0% | - | |
| Nov 10, 2025 | EBS Emergent Biosolutions Inc. | Degolyer Donald W54 | Director | Sell | 17,801 | $10.54 | $187,622.54 | -12.9% | +0.4% | - | |
| Nov 10, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael | President And COO | Sell | 22,500 | $452.07 | $10,171,683.00 | -100% | +4.2% | - | |
| Nov 10, 2025 | MRK Merck & Co., Inc. | Downing Cristal N | Chief Comm. &Public Afrs Ofcr | Sell | 7,085 | $87.00 | $616,395.00 | -100% | +35.6% | - | |
| Nov 10, 2025 | PCRX Pacira Biosciences, Inc. | Cross Shawn58 | Chief Financial Officer | Sell | 12,060 | $22.09 | $266,405.40 | -17.7% | -8.7% | - | |
| Nov 10, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 41,823 | $45.09 | $1,885,617.85 | -17.6% | +13.1% | - | |
| Nov 7, 2025 | LQDA Liquidia Corp | Boyle Dana | Chief Accounting Officer | Sell | 29,004 | $25.09 | $727,674.44 | -8.0% | +59.3% | - | |
| Nov 7, 2025 | GTBIF Green Thumb Industries Inc. | Kovler Benjamin | Chairman &CEO | Sell | 162,500 | $6.50 | $1,056,396.25 | -19.0% | - | - | |
| Nov 7, 2025 | EBS Emergent Biosolutions Inc. | Dayal Sujata Tyagi | Director | Sell | 8,552 | $10.00 | $85,520.00 | -8.8% | +3.7% | - | |
| Nov 7, 2025 | GTBIF Green Thumb Industries Inc. | Georgiadis Anthony | President | Sell | 125,000 | $6.50 | $812,575.00 | -14.1% | - | - | |
| Nov 7, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $448.41 | $3,587,315.90 | -63.2% | +6.7% | - | |
| Nov 7, 2025 | JNJ Johnson & Johnson | Johnson & Johnson59 | 10% Owner | Sell | 52,532 | $10.21 | $536,309.72 | -0.6% | +27.5% | - | |
| Nov 6, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Mignone Roberto | Director | Sell | 200,000 | $24.11 | $4,821,880.00 | -28.8% | +42.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.